Product Reviews
Categories
- Alternative Medicine
- Cancer
- Acute Promyelocytic Leukemia
- Anal Cancer
- Bladder Cancer
- Breast cancer
- Colorectal cancer
- Endometrial Cancer
- Esophageal Cancer
- Gallbladder cancer
- Gastric Cancer
- Glioblastma
- Head and Neck Cancer
- Liver Cancer
- Lung Cancer
- Lymphoma
- Melanoma
- Nasopharyngeal Cancer
- Non-Hodgkin's Disease
- Ovarian Cancer
- Pancreatic Cancer
- Prostate cancer
- Renal Cancer
- Thyroid Cancer
- Cardiovascular disease
- Central Nervous System
- Constipation
- Diabetes
- Fatty Liver
- Irritable Bowel Syndrome
- Longevity
- Motherhood
- Obesity
- Others
- Psoriasis
- Respiratory Disease
- Rheumatoid Arthritis
Archives
Monthly Archives: December 2010
Pertuzumab Plus Herceptin Shows Promise in Early Breast Cancer
Just after four cycles of neoadjuvant use, the combination of Roche’s pertuzumab, Herceptin (trastuzumab) and chemotherapy improved the rate of complete tumor disappearance by more than half compared to conventional therapy in patients with HER2-positive breast cancer. The results came … Continue reading
Posted in Breast cancer, Cancer
Tagged Breast cancer, HER2-positive, Herceptin, neoadjuvant, NEOSPHERE, Pertuzumab, Trastuzumab, tumor disappearance
Comments Off on Pertuzumab Plus Herceptin Shows Promise in Early Breast Cancer
FDA Approves the First Drug for Tuberous Sclerosis Tumors
Good news for patients with subependymal giant cell astrocytoma (SEGA). The US Food and Drug Administration (FDA) has granted the approval for everolimus (Afinitor, Novartis) as the first medication for children and adults with SEGA who require therapeutic intervention but … Continue reading
Posted in Cancer
Tagged Afinitor, Everolimus, subependymal giant cell astrocytoma, Tuberous Sclerosis Tumors, tumor, tumor shrinkage
Comments Off on FDA Approves the First Drug for Tuberous Sclerosis Tumors
